Identifying cancer genes' multiple personalities

byCold Spring Harbor LaboratoryAn up-close look at a mouse's liver; the cells with dark centers were turned cancerous using a new gene-editing strategy devised by Semir Beyaz's lab. Cred

Updated on: January 04,2024

Identifying cancer genes' multiple personalities

byCold Spring Harbor LaboratoryAn up-close look at a mouse's liver; the cells with dark centers were turned cancerous using a new gene-editing strategy devised by Semir Beyaz's lab. Cred

Updated on:January 04,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024

Spread of deadly eye cancer halted in cells and animals

by Johns Hopkins University School of MedicineGreen retinoblastoma cells in a zebra fish eye. Credit: David White, Jeff MummBy comparing genetic sequences in the eye tumors of children whose canc

Updated on: April 09,2024

Spread of deadly eye cancer halted in cells and animals

by Johns Hopkins University School of MedicineGreen retinoblastoma cells in a zebra fish eye. Credit: David White, Jeff MummBy comparing genetic sequences in the eye tumors of children whose canc

Updated on:April 09,2024

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on: October 01,2024

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on:October 01,2024

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on: July 11,2024

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on:July 11,2024

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on: January 30,2024

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on:January 30,2024

Study gauges specific site stomach cancer risks among ethnic groups

by Vanderbilt University Medical CenterCredit: CC0 Public DomainNon-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic

Updated on: April 20,2024

Study gauges specific site stomach cancer risks among ethnic groups

by Vanderbilt University Medical CenterCredit: CC0 Public DomainNon-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic

Updated on:April 20,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024

Aromatherapy and reflexology ease side effects for cancer patients

by Amanda Harper,The Ohio State UniversityCredit: CC0 Public DomainA noninvasive approach using aromatherapy and reflexology can dramatically reduce pain and anxiety for women undergoing cervica

Updated on: April 14,2024

Aromatherapy and reflexology ease side effects for cancer patients

by Amanda Harper,The Ohio State UniversityCredit: CC0 Public DomainA noninvasive approach using aromatherapy and reflexology can dramatically reduce pain and anxiety for women undergoing cervica

Updated on:April 14,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on: January 12,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on:January 12,2024

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Updated on: January 07,2024

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Updated on:January 07,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on: April 30,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on:April 30,2024